Belgian firm Amnovis is commercializing its deep titanium 3D printing and implant experience by helping other medical firms, startups and inventors bring their products to market. Through the company’s manufacturing and engineering expertise companies can accelerate their time to market and rent rare expertise. Now, Amnovis has an FDA Master File that lays out all the relevant information for its pure titanium (Grade 1) and titanium Ti-6Al-4V ELI (Grade 23) for powder bed fusion.

A Master File is a confidential disclosure to the FDA that outlines a drug, packaging or information about a manufacturing site, including the procedures that a firm follows. Master Files can relate to “facilities and manufacturing procedures and controls,”contract packaging and other manufacturing” and facilitate the FDA´s understanding of manufacturing procedures in place at a firm. In Amnovis´s case, the company qualified 3D printing processes for standard and patient-specific devices using validated Ti grade 1 and Ti-6Al-4V grade 23 materials.
Amnovis hopes that the file will facilitate regulatory approvals for itself and its customers. The FDA has been remarkably proactive about 3D printing in general, clearly hoping to be the default regulator for 3D printing in implantology and beyond. While Europe is coming to terms with new EU medical device directives which make it seem stricter than the US, the FDA has moved itself into pole position as the regulator for additive.
Smart move. The FDA has been more than welcoming to standard 3D printed medical devices in titanium, but it has been much more hesitant around patient-specific devices.
As I have stated before, through my own conversations, I´ve discovered that custom medical devices may sound lovely, but what if we could just go from five sizes to 30, rather than an infinite number? That would be safer and more than adequate to mitigate blood loss and encourage quicker recovery times and shorter procedures. For more discussion on this you can check out the two 3DPod´s below.
3DPOD Episode 138: Point-of-Care Medical Device 3D Printing with Dr. Steven Kurtz, Drexel University
3DPOD Episode 123: Dale Swarts, 3D Printed Orthopedic Implants, and More
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
You May Also Like
Billion Dollar Bambu and a New Worldview?
Imagine for a moment that Bambu Lab sells 2.7 million 3D printers this year. If their average ticket price is $350 and they generate $75 million in filament sales, their...
Printing Money Episode 26: 3D Printing Markets and Deals with Dayton Horvath, AMT
Welcome to Printing Money Episode 26! For this episode, Danny is joined by Dayton Horvath, Director of Emerging Technology at AMT (and Printing Money alum!). Danny and Dayton had some...
Origin Shareholders Escalate Legal Battle Against Stratasys Over Earn-Out Payments
A legal dispute between Fortis Advisors LLC, representing former shareholders of Origin Laboratories, and 3D printing stalwart Stratasys Ltd. has escalated with a new fraud lawsuit filed in December 2024....
Analysis: Additive Manufacturing Strategies Spotlights Vertical Value Creation
A slowdown in the industry and particularly a tightening of access to capital following the additive manufacturing (AM) industry’s peak special purpose acquisition company (SPAC) phase in early 2021 is...